Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options
- PMID: 34453529
- PMCID: PMC8824518
- DOI: 10.1093/europace/euab178
Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options
Abstract
Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of acquired or inherited cardiac diseases associated with a high risk of sudden cardiac death due to ventricular tachyarrhythmias. Contemporary ICD devices offer reliable arrhythmia detection and discrimination algorithms and deliver highly efficient tachytherapies. Percutaneously inserted transvenous defibrillator coils with pectoral generator placement are the first-line approach in the majority of adults due to their extensively documented clinical benefit and efficiency with comparably low periprocedural implantation risks as well as the option of providing pain-free tachycardia treatment via anti-tachycardia pacing (ATP), concomitant bradycardiaprotection, and incorporation in a cardiac resynchronization therapy if indicated. Yet, expanding ICD indications particularly among younger and more complex patient groups as well as the increasingly evident long-term consequences and complications associated with intravascular lead placements promoted the development of alternative ICD configurations. Most established in daily clinical practice is the subcutaneous ICD but other innovative extravascular approaches like epicardial, pericardial, extra-pleural, and most recently substernal defibrillator coil placements have been introduced as well to overcome shortcomings associated with traditional devices and allow for individualized treatment strategies tailored to the patients characteristics and needs. The review aims to provide practical solutions for common complications encountered with transvenous ICD systems including restricted venous access, high defibrillation/fibrillation thresholds (DFTs), and recurrent device infections. We summarize the contemporary options for non-traditional extravascular ICD configurations outlining indications, advantages, and disadvantages.
Keywords: Epicardial implantable cardioverter-defibrillator; Extra-pleural implantable cardioverter-defibrillator; High defibrillation/fibrillation threshold; Hybrid implantable cardioverter-defibrillator configurations; Non-traditional implantable cardioverter-defibrillator; Subcutaneous implantable cardioverter-defibrillator; Substernal implantable cardioverter-defibrillator; Venous access crisis.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures



Similar articles
-
New Horizons in Nontransvenous Arrhythmia Management: Aurora Extravascular ICD.J Cardiothorac Vasc Anesth. 2025 Jun;39(6):1564-1570. doi: 10.1053/j.jvca.2025.01.029. Epub 2025 Jan 25. J Cardiothorac Vasc Anesth. 2025. PMID: 40133098 Review.
-
The subcutaneous ICD as an alternative to the conventional ICD system: Initial experience in Greece and a review of the literature.Hellenic J Cardiol. 2017 Jan-Feb;58(1):4-16. doi: 10.1016/j.hjc.2017.01.010. Epub 2017 Feb 2. Hellenic J Cardiol. 2017. PMID: 28163146 Review.
-
Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.Curr Probl Cardiol. 2022 Sep;47(9):100927. doi: 10.1016/j.cpcardiol.2021.100927. Epub 2021 Jul 3. Curr Probl Cardiol. 2022. PMID: 34311985 Review.
-
Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20. Europace. 2013. PMID: 23333943
-
The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome.Eur Heart J. 2020 Jun 1;41(21):2003-2011. doi: 10.1093/eurheartj/ehz788. Eur Heart J. 2020. PMID: 31713598 Review.
Cited by
-
Ventricular Epicardial Adipose Distribution on Human Hearts: 3-Dimensional Reconstructions and Quantitative Assessments.J Cardiovasc Transl Res. 2024 Aug;17(4):959-968. doi: 10.1007/s12265-024-10505-x. Epub 2024 Apr 16. J Cardiovasc Transl Res. 2024. PMID: 38625670
-
Left inferior phrenic vein ICD lead implantation.HeartRhythm Case Rep. 2025 Mar 18;11(6):534-538. doi: 10.1016/j.hrcr.2025.03.010. eCollection 2025 Jun. HeartRhythm Case Rep. 2025. PMID: 40557395 Free PMC article. No abstract available.
-
Shock vector modulation via axillary vein coil in a right-sided implantable cardioverter-defibrillator.HeartRhythm Case Rep. 2023 Oct 9;9(12):935-938. doi: 10.1016/j.hrcr.2023.10.003. eCollection 2023 Dec. HeartRhythm Case Rep. 2023. PMID: 38204839 Free PMC article. No abstract available.
-
Subcutaneous cardioverter-defibrillator implantation in an adult with congenital heart disease and left infra-mammary pacemaker.Indian Pacing Electrophysiol J. 2024 Mar-Apr;24(2):111-113. doi: 10.1016/j.ipej.2023.12.008. Epub 2023 Dec 31. Indian Pacing Electrophysiol J. 2024. PMID: 38169171 Free PMC article.
-
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.Europace. 2023 Jul 4;25(7):euad184. doi: 10.1093/europace/euad184. Europace. 2023. PMID: 37379530 Free PMC article.
References
-
- Boczar K, Ząbek A, Haberka K, Hardzina M, Dębski M, Rydlewska A et al. Venous stenosis and occlusion in the presence of endocardial leads. Adv Clin Exp Med 2016;25:83–91. - PubMed
-
- Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009;6:605–10. - PubMed
-
- Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Cardiac perforation from implantable cardioverter defibrillator lead placement. Insights from the National. Circ Cardiovasc Qual Outcomes 2013;6:582–90. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical